Resverlogix Provides Update on BETonMACE Phase 3 Epigenetics Trial

NEXT STORY
Global RNA Based Therapeutics Market Worth Reach USD 1.97 Billion By 2025: Zion Market Research
PREV STORY
Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Teleflex Announces Second Quarter 2020 Earnings Conference Call Information

author_avatar
NASDAQ Market News

NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir

author_avatar
NASDAQ Market News

BeiGene to Hold Conference Call and Webcast on September 8, 2019 at 7:00 p.m. ET to Provide Corporate Update

author_avatar
NASDAQ Market News